Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Epidermal growth factor receptor-tyrosine kinase inhibitors have improved progression-free survival and overall survival in non-small-cell lung cancer (NSCLC) patients with sensitive mutations. However, response of uncommon mutation to epidermal growth factor receptor-tyrosine kinase inhibitors is s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Onco Targets Ther
Auteurs principaux: Duan, Hua, Peng, Yanmei, Cui, Huijuan, Qiu, Yuqin, Li, Qiang, Zhang, Jingyi, Shen, Wen, Sun, Chenyao, Luo, Chufan
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5923252/
https://ncbi.nlm.nih.gov/pubmed/29731638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S151125
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires